Bluefish Pharmaceuticals
Sachin Patil is an experienced professional in Quality Assurance within the pharmaceutical industry, currently serving as Senior Quality Assurance Manager at Bluefish Pharmaceuticals since November 2016, where responsibilities include leading supplier audits across various manufacturers and laboratories in Asia and Europe. Prior to Bluefish, Sachin held managerial roles at Centaur Pharmaceuticals Pvt. Ltd. and Micro Labs Limited, focusing on quality assurance for oral solids and sterile dosage forms. Sachin's early career began at FDC Limited and Neon Laboratories Limited, contributing to quality control and documentation processes. Educational qualifications include a Bachelor's degree in Pharmacy from Govt. College of Pharmacy, KARAD, and an MBA in Operations from Indira Gandhi National Open University.
This person is not in the org chart
This person is not in any offices
Bluefish Pharmaceuticals
Founded in Sweden, with its long tradition of industrial entrepreneurship, Bluefish Pharmaceuticals has become one of the most progressive generics pharmaceuticals companies. At Bluefish, we strive to make quality medicines accessible to more people. We create value in the full pharmaceutical value chain from developing to manufacturing and successfully marketing generic pharmaceuticals and we take pride in doing this in an innovative, responsible and cost-efficient way. Bluefish currently conducts operations in 19 countries in Europe and, over the next few years, will also expand outside Europe with the aim of becoming a global player. Our corporate culture and close collaboration with development and manufacturing partners are integral parts of our effort to deliver quality products at affordable prices. We offer a product portfolio consisting of a broad range of high quality generics for all major therapeutic areas. It is part of our long-term strategy to expand the product portfolio of off-patent blockbusters while at the same time offering a broader range of niche products within more narrow disease areas.